Risk of fracture in patients with non-valvular atrial fibrillation initiating direct oral anticoagulants vs. vitamin K antagonists.
第一作者:
Na,He
第一单位:
Department of Pharmacy, Peking University Third Hospital, 49 Huayuan North Road, Beijing 100191, China.;Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, 3755 Cote Sainte-Catherine Road, Montreal, Québec H3T 1E2, Canada.;Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, 1020 Pine Avenue West, Montreal, Québec H3A 1A2, Canada.
作者:
主题词
投药, 口服(Administration, Oral);成年人(Adult);抗凝药(Anticoagulants);心房颤动(Atrial Fibrillation);纤维蛋白溶解药(Fibrinolytic Agents);人类(Humans);维生素K(Vitamin K)
DOI
10.1093/ehjcvp/pvaa094
PMID
32722764
发布时间
2024-08-15
- 浏览0

European heart journal. Cardiovascular pharmacotherapy
2021年7卷5期
389-397页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文